Hiromi Matsumoto

Chuo, 1030027, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Implementing generative artificial intelligence in precision oncology: safety, governance, and significance.

Implementing generative artificial intelligence in precision oncology: safety, governance, and significance.

Journal: Journal of hematology & oncology

Published: November 02, 2025

A clinically applicable and generalizable deep learning model for anterior mediastinal tumors in CT images across multiple institutions.

A clinically applicable and generalizable deep learning model for anterior mediastinal tumors in CT images across multiple institutions.

Journal: Scientific reports

Published: May 19, 2025

Impact Assessment of an Antimicrobial Stewardship Program in a Japanese University Dental Hospital.

Impact Assessment of an Antimicrobial Stewardship Program in a Japanese University Dental Hospital.

Journal: International dental journal

Published: February 03, 2025

MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer.

MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer.

Journal: Translational lung cancer research

Published: January 30, 2025

Dissecting regional variability in Pyrazinamide prescribing practices for tuberculosis treatment in Japan.

Dissecting regional variability in Pyrazinamide prescribing practices for tuberculosis treatment in Japan.

Journal: Journal of clinical tuberculosis and other mycobacterial diseases

Published: December 10, 2024

Impact of Direct Observation on Hand Hygiene Compliance in a Dental University Hospital: A Retrospective Cohort Study.

Impact of Direct Observation on Hand Hygiene Compliance in a Dental University Hospital: A Retrospective Cohort Study.

Journal: Cureus

Published: September 06, 2024

Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthma.

Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthma.

Journal: European clinical respiratory journal

Published: July 30, 2024

HLA-DQA101:03 and DQB106:01 are risk factors for severe COVID-19 pneumonia.

HLA-DQA101:03 and DQB106:01 are risk factors for severe COVID-19 pneumonia.

Journal: HLA

Published: February 26, 2024

Employing a low-code machine learning approach to predict in-hospital mortality and length of stay in patients with community-acquired pneumonia.

Employing a low-code machine learning approach to predict in-hospital mortality and length of stay in patients with community-acquired pneumonia.

Journal: Scientific reports

Published: February 18, 2024

High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse.

High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse.

Journal: PloS one

Published: February 15, 2024

Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer.

Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer.

Journal: Thoracic cancer

Published: February 02, 2024

Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel.

Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel.

Journal: Translational lung cancer research

Published: January 11, 2024

Showing 1-12 of 26

Last Updated: 09/26/2026